[1] Ilina O, Friedl P. Mechanisms of collective cell migration at a glance[J]. Cell Sci, 2009, 122(Pt 18):32033208.
[2] Thompson EW, Haviv I. The social aspects of EMTMET plasticity[J]. Nat Med, 2011, 17(9):10481049.
[3] Hao J, Zhang Y, Deng M, et al. MicroRNA control of epithelialmesenchymal transition in cancer stem cells[J]. Int J Cancer, 2014, 135(5):10191027.
[4] Cowin P, Wysolmerski J. Molecular mechanisms guiding embryonic mammary gland development[J]. Cold Spring Harb Perspect Biol, 2010, 2(6):a003251.
[5] Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer[J]. Am Pathol, 2011, 178(3):989996.
[6] Kallergi G, Papadaki MA, Politaki E, et al. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients[J]. Breast Cancer Res, 2011, 13(3):R59.
[7] Kallergi G, Konstantinidis G, Markomanolaki H, et al. Apoptotic circulating tumor cells in early and metastatic breast cancer patients[J]. Mol Cancer Ther, 2013, 12(9):18861895.
[8] Bonnomet A, Brysse A, Tachsidis A, et al. Epithelialtomesenchymal transitions and circulating tumor cells[J]. Mammary Gland Biol Neoplasia, 2010, 15(2):261273.
[9] Dondossola E, Rangel R, GuzmanRojas L, et al. CD13positive bone marrowderived myeloid cells promote angiogenesis, tumor growth, and metastasis[J]. Proc Natl Acad Sci USA, 2013, 110(51):2071720722.
[10] Shaked Y, McAllister S, Fainaru O, et al. Tumor dormancy and the angiogenic switch: possible implications of bone marrowderived cells[J]. Curr Pharm Des, 2014, 20(30):49204933.
[11] Fan Q, Gu D, Liu H, et al. Defective TGFbeta signaling in bone marrowderived cells prevents hedgehoginduced skin tumors[J]. Cancer Res, 2014, 74(2):471483.
[12] Peinado H, Aleckovic M, Lavotshkin S, et al.Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET[J]. Nat Med, 2012; 18(6):883891.
[13] Kumar S, Park SH, Cieply B, et al. A pathway for the control of anoikis sensitivity by Ecadherin and epithelialtomesenchymal transition[J]. Mol Cell Biol, 2011, 31(19):40364051.
[14] Park SH, Riley P 4th, Frisch SM. Regulation of anoikis by deleted in breast cancer1 (DBC1) through NFkappaB[J]. Apoptosis, 2013, 18(8):949962.
[15] Yao X, Choudhury AD, Yamanaka YJ, et al. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits[J]. Integr Biol (Camb), 2014, 6(4):388398.
[16] 周开华, 陈晓丹, 宋鑫. 恶性胸水培养肿瘤细胞失败原因分析[J]. 昆明医学院学报, 2011, 32(5):4749,57.
[17] Desitter I, Guerrouahen BS, BenaliFuret N, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells[J]. Anticancer Res, 2011, 31(2):427441.
[18] Lin HK, Zheng S, Williams AJ, et al. Portable filterbased microdevice for detection and characterization of circulating tumor cells[J]. Clin Cancer Res, 2010, 16(20):50115018.
[19] Hou JM, Krebs MG, Lancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with smallcell lung cancer[J]. J Clin Oncol, 2012, 30(5):525532.
[20] Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortexgenerating herringbonechip[J]. Proc Natl Acad Sci USA, 2010, 107(43):1839218397.
[21] Zheng S, Lin HK, Lu B, et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood[J]. Biomed Microdevices, 2011, 13(1):203213.
[22] Krebs MG, Hou JM, Sloane R, et al.Analysis of circulating tumor cells in patients with nonsmall cell lung cancer using epithelial markerdependent and independent approaches[J]. Thorac Oncol, 2012, 7(2):306315.
[23] Ma YC, Wang L, Yu FL, et al. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology[J]. Technol Cancer Res Treat, 2013, 12(4):295309.
[24] Tinhofer I, Saki M, Niehr F, et al. Cancer stem cell characteristics of circulating tumor cells[J]. Int J Radiat Biol, 2014, 90(8):622627. |